Tianjin Development (00882.HK) subsidiary subscribes to 50 million yuan financial products.

Wisdom Financial News APP reported that Tianjin Development (00882.HK) issued an announcement on June 19, 2025. Lisheng Pharmaceutical (an indirectly non-wholly-owned subsidiary of the company) entered into the ninth wealth management agreement with Xingyin Wealth Management and Xingye Bank, subscribing to another fixed-income investment product with a principal amount of 50 million yuan.